Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06860945

Development of a Predictive Model for Sexually Transmitted Infections in Individuals Using Pre-Exposure Prophylaxis for HIV in Spain

Status
Recruiting
Phase
Study type
Observational
Enrollment
9,000 (estimated)
Sponsor
Hospital Universitario de Valme · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Accepted

Summary

Objective: To develop and validate a predictive model for acquiring sexually transmitted infections (STIs) in individuals using HIV pre-exposure prophylaxis (PrEP) within the national program providing this strategy. Methods: Ambispective cohort study, multicentric (23 Spanish hospitals). All PrEP users, with follow-up within the program, will be included. Entry into the program will be considered as the baseline visit. From there, patients are followed quarterly, following the national protocols for monitoring PrEP users in Spain. At each visit, diagnosis of different STIs (serum, pharyngeal swab, urethral or urine sample, rectal swab, endocervical/vaginal swab, ulcer) is performed. Primary outcome variable: development of an STI (Yes/No). The following STIs will be considered: syphilis, Neisseria gonorrhoeae (NG) infection, Chlamydia trachomatis (CT) infection, lymphogranuloma venereum (LGV), Mycoplasma genitalium (MG) infection, genital herpes, hepatitis A, hepatitis B, hepatitis C, HIV infection, and MPOX. Secondary outcome variable: number of diagnosed STIs. In order to determine factors associated with acquiring an STI, multivariate analyses will be conducted using logistic regression. The best models will be analyzed in the validation population. To compare the models, we will follow the Bayesian approach suggested by Benavoli et al.

Conditions

Interventions

TypeNameDescription
OTHERNo Intervention: Observational CohortNo Intervention: Observational Cohort

Timeline

Start date
2025-01-01
Primary completion
2025-06-30
Completion
2026-01-01
First posted
2025-03-06
Last updated
2025-03-06

Locations

26 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT06860945. Inclusion in this directory is not an endorsement.